【市場調査レポート】ベルパタスビルのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Velpatasvir Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ベルパタスビルのグローバル市場インサイト・予測（～2028年） / Global Velpatasvir Market Insights, Forecast to 2028 / QY2207E02839資料のイメージです。

• レポートコード：QY2207E02839
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、74ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のベルパタスビルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にベルパタスビルの世界市場のxxx％を占める「純度98.0％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「C型肝炎」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のベルパタスビルの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのベルパタスビル市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのベルパタスビル市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ベルパタスビルのグローバル主要メーカーには、Mylan Laboratories、Century Pharmaceuticals、PharmaResources (Shanghai)などがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ベルパタスビル市場は、種類と用途によって区分されます。世界のベルパタスビル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
純度98.0％以上、純度98.0％以下

【用途別セグメント】
C型肝炎、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ベルパタスビル製品概要
- 種類別市場（純度98.0％以上、純度98.0％以下）
- 用途別市場（C型肝炎、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のベルパタスビル販売量予測2017-2028
- 世界のベルパタスビル売上予測2017-2028
- ベルパタスビルの地域別販売量
- ベルパタスビルの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ベルパタスビル販売量
- 主要メーカー別ベルパタスビル売上
- 主要メーカー別ベルパタスビル価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（純度98.0％以上、純度98.0％以下）
- ベルパタスビルの種類別販売量
- ベルパタスビルの種類別売上
- ベルパタスビルの種類別価格
・用途別市場規模（C型肝炎、その他）
- ベルパタスビルの用途別販売量
- ベルパタスビルの用途別売上
- ベルパタスビルの用途別価格
・北米市場
- 北米のベルパタスビル市場規模（種類別、用途別）
- 主要国別のベルパタスビル市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのベルパタスビル市場規模（種類別、用途別）
- 主要国別のベルパタスビル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のベルパタスビル市場規模（種類別、用途別）
- 主要国別のベルパタスビル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のベルパタスビル市場規模（種類別、用途別）
- 主要国別のベルパタスビル市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのベルパタスビル市場規模（種類別、用途別）
- 主要国別のベルパタスビル市場規模（トルコ、サウジアラビア）
・企業情報
Mylan Laboratories、Century Pharmaceuticals、PharmaResources (Shanghai)
・産業チェーン及び販売チャネル分析
- ベルパタスビルの産業チェーン分析
- ベルパタスビルの原材料
- ベルパタスビルの生産プロセス
- ベルパタスビルの販売及びマーケティング
- ベルパタスビルの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ベルパタスビルの産業動向
- ベルパタスビルのマーケットドライバー
- ベルパタスビルの課題
- ベルパタスビルの阻害要因
・主な調査結果

Market Analysis and Insights: Global Velpatasvir Market
Due to the COVID-19 pandemic, the global Velpatasvir market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Above 98.0% Purity accounting for % of the Velpatasvir global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hepatitis C segment is altered to an % CAGR throughout this forecast period.
China Velpatasvir market size is valued at US$ million in 2021, while the US and Europe Velpatasvir are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Velpatasvir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Velpatasvir include Mylan Laboratories, Century Pharmaceuticals and PharmaResources (Shanghai), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Velpatasvir capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Velpatasvir by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Velpatasvir Scope and Segment
Velpatasvir market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Velpatasvir market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Above 98.0% Purity
Below 98.0% Purity
Segment by Application
Hepatitis C
Other
By Company
Mylan Laboratories
Century Pharmaceuticals
PharmaResources (Shanghai)
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Velpatasvir Product Introduction
1.2 Market by Type
1.2.1 Global Velpatasvir Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Above 98.0% Purity
1.2.3 Below 98.0% Purity
1.3 Market by Application
1.3.1 Global Velpatasvir Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hepatitis C
1.3.3 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Velpatasvir Production
2.1 Global Velpatasvir Production Capacity (2017-2028)
2.2 Global Velpatasvir Production by Region: 2017 VS 2021 VS 2028
2.3 Global Velpatasvir Production by Region
2.3.1 Global Velpatasvir Historic Production by Region (2017-2022)
2.3.2 Global Velpatasvir Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Velpatasvir Sales in Volume & Value Estimates and Forecasts
3.1 Global Velpatasvir Sales Estimates and Forecasts 2017-2028
3.2 Global Velpatasvir Revenue Estimates and Forecasts 2017-2028
3.3 Global Velpatasvir Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Velpatasvir Sales by Region
3.4.1 Global Velpatasvir Sales by Region (2017-2022)
3.4.2 Global Sales Velpatasvir by Region (2023-2028)
3.5 Global Velpatasvir Revenue by Region
3.5.1 Global Velpatasvir Revenue by Region (2017-2022)
3.5.2 Global Velpatasvir Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Velpatasvir Production Capacity by Manufacturers
4.2 Global Velpatasvir Sales by Manufacturers
4.2.1 Global Velpatasvir Sales by Manufacturers (2017-2022)
4.2.2 Global Velpatasvir Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Velpatasvir in 2021
4.3 Global Velpatasvir Revenue by Manufacturers
4.3.1 Global Velpatasvir Revenue by Manufacturers (2017-2022)
4.3.2 Global Velpatasvir Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Velpatasvir Revenue in 2021
4.4 Global Velpatasvir Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Velpatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Velpatasvir Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Velpatasvir Sales by Type
5.1.1 Global Velpatasvir Historical Sales by Type (2017-2022)
5.1.2 Global Velpatasvir Forecasted Sales by Type (2023-2028)
5.1.3 Global Velpatasvir Sales Market Share by Type (2017-2028)
5.2 Global Velpatasvir Revenue by Type
5.2.1 Global Velpatasvir Historical Revenue by Type (2017-2022)
5.2.2 Global Velpatasvir Forecasted Revenue by Type (2023-2028)
5.2.3 Global Velpatasvir Revenue Market Share by Type (2017-2028)
5.3 Global Velpatasvir Price by Type
5.3.1 Global Velpatasvir Price by Type (2017-2022)
5.3.2 Global Velpatasvir Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Velpatasvir Sales by Application
6.1.1 Global Velpatasvir Historical Sales by Application (2017-2022)
6.1.2 Global Velpatasvir Forecasted Sales by Application (2023-2028)
6.1.3 Global Velpatasvir Sales Market Share by Application (2017-2028)
6.2 Global Velpatasvir Revenue by Application
6.2.1 Global Velpatasvir Historical Revenue by Application (2017-2022)
6.2.2 Global Velpatasvir Forecasted Revenue by Application (2023-2028)
6.2.3 Global Velpatasvir Revenue Market Share by Application (2017-2028)
6.3 Global Velpatasvir Price by Application
6.3.1 Global Velpatasvir Price by Application (2017-2022)
6.3.2 Global Velpatasvir Price Forecast by Application (2023-2028)
7 North America
7.1 North America Velpatasvir Market Size by Type
7.1.1 North America Velpatasvir Sales by Type (2017-2028)
7.1.2 North America Velpatasvir Revenue by Type (2017-2028)
7.2 North America Velpatasvir Market Size by Application
7.2.1 North America Velpatasvir Sales by Application (2017-2028)
7.2.2 North America Velpatasvir Revenue by Application (2017-2028)
7.3 North America Velpatasvir Sales by Country
7.3.1 North America Velpatasvir Sales by Country (2017-2028)
7.3.2 North America Velpatasvir Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Velpatasvir Market Size by Type
8.1.1 Europe Velpatasvir Sales by Type (2017-2028)
8.1.2 Europe Velpatasvir Revenue by Type (2017-2028)
8.2 Europe Velpatasvir Market Size by Application
8.2.1 Europe Velpatasvir Sales by Application (2017-2028)
8.2.2 Europe Velpatasvir Revenue by Application (2017-2028)
8.3 Europe Velpatasvir Sales by Country
8.3.1 Europe Velpatasvir Sales by Country (2017-2028)
8.3.2 Europe Velpatasvir Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Velpatasvir Market Size by Type
9.1.1 Asia Pacific Velpatasvir Sales by Type (2017-2028)
9.1.2 Asia Pacific Velpatasvir Revenue by Type (2017-2028)
9.2 Asia Pacific Velpatasvir Market Size by Application
9.2.1 Asia Pacific Velpatasvir Sales by Application (2017-2028)
9.2.2 Asia Pacific Velpatasvir Revenue by Application (2017-2028)
9.3 Asia Pacific Velpatasvir Sales by Region
9.3.1 Asia Pacific Velpatasvir Sales by Region (2017-2028)
9.3.2 Asia Pacific Velpatasvir Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Velpatasvir Market Size by Type
10.1.1 Latin America Velpatasvir Sales by Type (2017-2028)
10.1.2 Latin America Velpatasvir Revenue by Type (2017-2028)
10.2 Latin America Velpatasvir Market Size by Application
10.2.1 Latin America Velpatasvir Sales by Application (2017-2028)
10.2.2 Latin America Velpatasvir Revenue by Application (2017-2028)
10.3 Latin America Velpatasvir Sales by Country
10.3.1 Latin America Velpatasvir Sales by Country (2017-2028)
10.3.2 Latin America Velpatasvir Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Velpatasvir Market Size by Type
11.1.1 Middle East and Africa Velpatasvir Sales by Type (2017-2028)
11.1.2 Middle East and Africa Velpatasvir Revenue by Type (2017-2028)
11.2 Middle East and Africa Velpatasvir Market Size by Application
11.2.1 Middle East and Africa Velpatasvir Sales by Application (2017-2028)
11.2.2 Middle East and Africa Velpatasvir Revenue by Application (2017-2028)
11.3 Middle East and Africa Velpatasvir Sales by Country
11.3.1 Middle East and Africa Velpatasvir Sales by Country (2017-2028)
11.3.2 Middle East and Africa Velpatasvir Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Mylan Laboratories
12.1.1 Mylan Laboratories Corporation Information
12.1.2 Mylan Laboratories Overview
12.1.3 Mylan Laboratories Velpatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Mylan Laboratories Velpatasvir Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Mylan Laboratories Recent Developments
12.2 Century Pharmaceuticals
12.2.1 Century Pharmaceuticals Corporation Information
12.2.2 Century Pharmaceuticals Overview
12.2.3 Century Pharmaceuticals Velpatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Century Pharmaceuticals Velpatasvir Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Century Pharmaceuticals Recent Developments
12.3 PharmaResources (Shanghai)
12.3.1 PharmaResources (Shanghai) Corporation Information
12.3.2 PharmaResources (Shanghai) Overview
12.3.3 PharmaResources (Shanghai) Velpatasvir Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 PharmaResources (Shanghai) Velpatasvir Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 PharmaResources (Shanghai) Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Velpatasvir Industry Chain Analysis
13.2 Velpatasvir Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Velpatasvir Production Mode & Process
13.4 Velpatasvir Sales and Marketing
13.4.1 Velpatasvir Sales Channels
13.4.2 Velpatasvir Distributors
13.5 Velpatasvir Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Velpatasvir Industry Trends
14.2 Velpatasvir Market Drivers
14.3 Velpatasvir Market Challenges
14.4 Velpatasvir Market Restraints
15 Key Finding in The Global Velpatasvir Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Velpatasvir Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Above 98.0% Purity
Table 3. Major Manufacturers of Below 98.0% Purity
Table 4. Global Velpatasvir Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Velpatasvir Production by Region: 2017 VS 2021 VS 2028 (Tons)
Table 6. Global Velpatasvir Production by Region (2017-2022) & (Tons)
Table 7. Global Velpatasvir Production Market Share by Region (2017-2022)
Table 8. Global Velpatasvir Production by Region (2023-2028) & (Tons)
Table 9. Global Velpatasvir Production Market Share by Region (2023-2028)
Table 10. Global Velpatasvir Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Velpatasvir Sales by Region (2017-2022) & (Tons)
Table 12. Global Velpatasvir Sales Market Share by Region (2017-2022)
Table 13. Global Velpatasvir Sales by Region (2023-2028) & (Tons)
Table 14. Global Velpatasvir Sales Market Share by Region (2023-2028)
Table 15. Global Velpatasvir Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Velpatasvir Revenue Market Share by Region (2017-2022)
Table 17. Global Velpatasvir Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Velpatasvir Revenue Market Share by Region (2023-2028)
Table 19. Global Velpatasvir Production Capacity by Manufacturers (2017-2022) & (Tons)
Table 20. Global Velpatasvir Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Velpatasvir Sales by Manufacturers (2017-2022) & (Tons)
Table 22. Global Velpatasvir Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Velpatasvir Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Velpatasvir Revenue Share by Manufacturers (2017-2022)
Table 25. Velpatasvir Price by Manufacturers 2017-2022 (US$/Ton)
Table 26. Global Velpatasvir Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Velpatasvir by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Velpatasvir as of 2021)
Table 28. Velpatasvir Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Velpatasvir Product Offered
Table 30. Date of Manufacturers Enter into Velpatasvir Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Velpatasvir Sales by Type (2017-2022) & (Tons)
Table 33. Global Velpatasvir Sales by Type (2023-2028) & (Tons)
Table 34. Global Velpatasvir Sales Share by Type (2017-2022)
Table 35. Global Velpatasvir Sales Share by Type (2023-2028)
Table 36. Global Velpatasvir Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Velpatasvir Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Velpatasvir Revenue Share by Type (2017-2022)
Table 39. Global Velpatasvir Revenue Share by Type (2023-2028)
Table 40. Velpatasvir Price by Type (2017-2022) & (US$/Ton)
Table 41. Global Velpatasvir Price Forecast by Type (2023-2028) & (US$/Ton)
Table 42. Global Velpatasvir Sales by Application (2017-2022) & (Tons)
Table 43. Global Velpatasvir Sales by Application (2023-2028) & (Tons)
Table 44. Global Velpatasvir Sales Share by Application (2017-2022)
Table 45. Global Velpatasvir Sales Share by Application (2023-2028)
Table 46. Global Velpatasvir Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Velpatasvir Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Velpatasvir Revenue Share by Application (2017-2022)
Table 49. Global Velpatasvir Revenue Share by Application (2023-2028)
Table 50. Velpatasvir Price by Application (2017-2022) & (US$/Ton)
Table 51. Global Velpatasvir Price Forecast by Application (2023-2028) & (US$/Ton)
Table 52. North America Velpatasvir Sales by Type (2017-2022) & (Tons)
Table 53. North America Velpatasvir Sales by Type (2023-2028) & (Tons)
Table 54. North America Velpatasvir Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Velpatasvir Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Velpatasvir Sales by Application (2017-2022) & (Tons)
Table 57. North America Velpatasvir Sales by Application (2023-2028) & (Tons)
Table 58. North America Velpatasvir Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Velpatasvir Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Velpatasvir Sales by Country (2017-2022) & (Tons)
Table 61. North America Velpatasvir Sales by Country (2023-2028) & (Tons)
Table 62. North America Velpatasvir Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Velpatasvir Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Velpatasvir Sales by Type (2017-2022) & (Tons)
Table 65. Europe Velpatasvir Sales by Type (2023-2028) & (Tons)
Table 66. Europe Velpatasvir Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Velpatasvir Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Velpatasvir Sales by Application (2017-2022) & (Tons)
Table 69. Europe Velpatasvir Sales by Application (2023-2028) & (Tons)
Table 70. Europe Velpatasvir Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Velpatasvir Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Velpatasvir Sales by Country (2017-2022) & (Tons)
Table 73. Europe Velpatasvir Sales by Country (2023-2028) & (Tons)
Table 74. Europe Velpatasvir Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Velpatasvir Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Velpatasvir Sales by Type (2017-2022) & (Tons)
Table 77. Asia Pacific Velpatasvir Sales by Type (2023-2028) & (Tons)
Table 78. Asia Pacific Velpatasvir Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Velpatasvir Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Velpatasvir Sales by Application (2017-2022) & (Tons)
Table 81. Asia Pacific Velpatasvir Sales by Application (2023-2028) & (Tons)
Table 82. Asia Pacific Velpatasvir Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Velpatasvir Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Velpatasvir Sales by Region (2017-2022) & (Tons)
Table 85. Asia Pacific Velpatasvir Sales by Region (2023-2028) & (Tons)
Table 86. Asia Pacific Velpatasvir Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Velpatasvir Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Velpatasvir Sales by Type (2017-2022) & (Tons)
Table 89. Latin America Velpatasvir Sales by Type (2023-2028) & (Tons)
Table 90. Latin America Velpatasvir Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Velpatasvir Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Velpatasvir Sales by Application (2017-2022) & (Tons)
Table 93. Latin America Velpatasvir Sales by Application (2023-2028) & (Tons)
Table 94. Latin America Velpatasvir Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Velpatasvir Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Velpatasvir Sales by Country (2017-2022) & (Tons)
Table 97. Latin America Velpatasvir Sales by Country (2023-2028) & (Tons)
Table 98. Latin America Velpatasvir Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Velpatasvir Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Velpatasvir Sales by Type (2017-2022) & (Tons)
Table 101. Middle East and Africa Velpatasvir Sales by Type (2023-2028) & (Tons)
Table 102. Middle East and Africa Velpatasvir Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Velpatasvir Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Velpatasvir Sales by Application (2017-2022) & (Tons)
Table 105. Middle East and Africa Velpatasvir Sales by Application (2023-2028) & (Tons)
Table 106. Middle East and Africa Velpatasvir Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Velpatasvir Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Velpatasvir Sales by Country (2017-2022) & (Tons)
Table 109. Middle East and Africa Velpatasvir Sales by Country (2023-2028) & (Tons)
Table 110. Middle East and Africa Velpatasvir Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Velpatasvir Revenue by Country (2023-2028) & (US$ Million)
Table 112. Mylan Laboratories Corporation Information
Table 113. Mylan Laboratories Description and Major Businesses
Table 114. Mylan Laboratories Velpatasvir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 115. Mylan Laboratories Velpatasvir Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Mylan Laboratories Recent Development
Table 117. Century Pharmaceuticals Corporation Information
Table 118. Century Pharmaceuticals Description and Major Businesses
Table 119. Century Pharmaceuticals Velpatasvir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 120. Century Pharmaceuticals Velpatasvir Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Century Pharmaceuticals Recent Development
Table 122. PharmaResources (Shanghai) Corporation Information
Table 123. PharmaResources (Shanghai) Description and Major Businesses
Table 124. PharmaResources (Shanghai) Velpatasvir Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
Table 125. PharmaResources (Shanghai) Velpatasvir Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. PharmaResources (Shanghai) Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Velpatasvir Distributors List
Table 130. Velpatasvir Customers List
Table 131. Velpatasvir Market Trends
Table 132. Velpatasvir Market Drivers
Table 133. Velpatasvir Market Challenges
Table 134. Velpatasvir Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Velpatasvir Product Picture
Figure 2. Global Velpatasvir Market Share by Type in 2021 & 2028
Figure 3. Above 98.0% Purity Product Picture
Figure 4. Below 98.0% Purity Product Picture
Figure 5. Global Velpatasvir Market Share by Application in 2021 & 2028
Figure 6. Hepatitis C
Figure 7. Other
Figure 8. Velpatasvir Report Years Considered
Figure 9. Global Velpatasvir Capacity, Production and Utilization (2017-2028) & (Tons)
Figure 10. Global Velpatasvir Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Velpatasvir Production Market Share by Region (2017-2022)
Figure 12. Global Velpatasvir Production Market Share by Region (2023-2028)
Figure 13. Velpatasvir Production Growth Rate in North America (2017-2028) & (Tons)
Figure 14. Velpatasvir Production Growth Rate in Europe (2017-2028) & (Tons)
Figure 15. Velpatasvir Production Growth Rate in China (2017-2028) & (Tons)
Figure 16. Velpatasvir Production Growth Rate in Japan (2017-2028) & (Tons)
Figure 17. Global Velpatasvir Sales 2017-2028 (Tons)
Figure 18. Global Velpatasvir Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Velpatasvir Revenue 2017-2028 (US$ Million)
Figure 20. Global Velpatasvir Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Velpatasvir Sales Market Share by Region (2017-2022)
Figure 22. Global Velpatasvir Sales Market Share by Region (2023-2028)
Figure 23. North America Velpatasvir Sales YoY (2017-2028) & (Tons)
Figure 24. North America Velpatasvir Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Velpatasvir Sales YoY (2017-2028) & (Tons)
Figure 26. Europe Velpatasvir Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Velpatasvir Sales YoY (2017-2028) & (Tons)
Figure 28. Asia-Pacific Velpatasvir Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Velpatasvir Sales YoY (2017-2028) & (Tons)
Figure 30. Latin America Velpatasvir Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Velpatasvir Sales YoY (2017-2028) & (Tons)
Figure 32. Middle East & Africa Velpatasvir Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Velpatasvir Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Velpatasvir in the World: Market Share by Velpatasvir Revenue in 2021
Figure 35. Velpatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Velpatasvir Sales Market Share by Type (2017-2028)
Figure 37. Global Velpatasvir Revenue Market Share by Type (2017-2028)
Figure 38. Global Velpatasvir Sales Market Share by Application (2017-2028)
Figure 39. Global Velpatasvir Revenue Market Share by Application (2017-2028)
Figure 40. North America Velpatasvir Sales Market Share by Type (2017-2028)
Figure 41. North America Velpatasvir Revenue Market Share by Type (2017-2028)
Figure 42. North America Velpatasvir Sales Market Share by Application (2017-2028)
Figure 43. North America Velpatasvir Revenue Market Share by Application (2017-2028)
Figure 44. North America Velpatasvir Sales Share by Country (2017-2028)
Figure 45. North America Velpatasvir Revenue Share by Country (2017-2028)
Figure 46. United States Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Velpatasvir Sales Market Share by Type (2017-2028)
Figure 49. Europe Velpatasvir Revenue Market Share by Type (2017-2028)
Figure 50. Europe Velpatasvir Sales Market Share by Application (2017-2028)
Figure 51. Europe Velpatasvir Revenue Market Share by Application (2017-2028)
Figure 52. Europe Velpatasvir Sales Share by Country (2017-2028)
Figure 53. Europe Velpatasvir Revenue Share by Country (2017-2028)
Figure 54. Germany Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 55. France Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Velpatasvir Sales Market Share by Type (2017-2028)
Figure 60. Asia Pacific Velpatasvir Revenue Market Share by Type (2017-2028)
Figure 61. Asia Pacific Velpatasvir Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Velpatasvir Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Velpatasvir Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Velpatasvir Revenue Share by Region (2017-2028)
Figure 65. China Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 68. India Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Velpatasvir Sales Market Share by Type (2017-2028)
Figure 75. Latin America Velpatasvir Revenue Market Share by Type (2017-2028)
Figure 76. Latin America Velpatasvir Sales Market Share by Application (2017-2028)
Figure 77. Latin America Velpatasvir Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Velpatasvir Sales Share by Country (2017-2028)
Figure 79. Latin America Velpatasvir Revenue Share by Country (2017-2028)
Figure 80. Mexico Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Velpatasvir Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Velpatasvir Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Velpatasvir Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Velpatasvir Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Velpatasvir Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Velpatasvir Revenue Share by Country (2017-2028)
Figure 89. Turkey Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Velpatasvir Revenue (2017-2028) & (US$ Million)
Figure 92. Velpatasvir Value Chain
Figure 93. Velpatasvir Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

以下、関連資料のご紹介

炭酸ジブチルのグローバル市場インサイト・予測（～2028年）

Global Di-n-butyl Carbonate Market Insights, Forecast to 2028
QY2207C1105 2022年7月8日 96Pages
新型コロナウイルス感染症のパンデミックにより、世界の炭酸ジブチルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に炭酸ジブチルの世界市...

パラ系アラミド断熱紙のグローバル市場インサイト・予測（～2028年）

Global Para-Aramid Insulation Paper Market Insights, Forecast to 2028
QY2207E01884 2022年7月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のパラ系アラミド断熱紙の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパラ系アラミド断...

シリコーン柔軟剤のグローバル市場インサイト・予測（～2028年）

Global Silicone Softener Market Insights, Forecast to 2028
QY2207E02414 2022年7月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界のシリコーン柔軟剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にシリコーン柔軟剤の世...

高安定性熱伝達流体のグローバル市場インサイト・予測（～2028年）

Global Highly Stable Heat Transfer Fluids Market Insights, Forecast to 2028
QY2207E01129 2022年7月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界の高安定性熱伝達流体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に高安定性熱伝達流体...

アラミドナノファイバー(ANF)のグローバル市場インサイト・予測（～2028年）

Global Aramid Nanofibers (ANFs) Market Insights, Forecast to 2028
QY2207E00907 2022年7月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界のアラミドナノファイバー(ANF)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアラ...

高純度臭化水素（HBr）のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Hydrogen Bromide (HBr) Market Due to the COVID-19 pandemic, the global High Purity Hydrogen Bromide (HBr) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the …
肝炎検査診断のグローバル市場インサイト・予測（～2028年） The purpose of hepatitis tests is to screen for and diagnose hepatitis, evaluate the liver, and to determine the underlying cause of hepatitis Common hepatitis tests include Enzyme-linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), Polymerase Chain Reaction (PCR), Isothermal Nucleic A…
高純度クロロトリフルオロエチレン（CTFE）のグローバル市場インサイト・予測（～2028年） Chlorotrifluoroethylene (CTEE for short) is a colorless gas at room temperature, toxic, its liquid is colorless transparent. It is chemically unstable and can burn. Mainly used in fluorine rubber, fluorine coating, fluorine chlorine oil, fluorine ether, animal anesthetics and pesticide intermediates…
世界の高純度有機金属市場予測（～2028年）：高純度有機スズ、高純度有機アルミニウム、高純度有機マグネシウム、高純度有機リチウム The High-purity Organometallics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
高純度一酸化窒素（NO）のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global High Purity Nitric Oxide (NO) Market Due to the COVID-19 pandemic, the global High Purity Nitric Oxide (NO) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast p…